EU regulator finds no safety issues with GSK, Merck HPV vaccines
LONDON (Reuters) - European drug regulators have found no safety concerns linking GlaxoSmithKline's and Merck's cervical cancer vaccines with two conditions known as complex regional pain syndrome (CRPS) and postural orthostatic tachycardia syndrome (POTS).
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Complex Regional Pain Syndrome | Health | Merck | Pain | Vaccines